XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period, preferred stock (in shares) at Dec. 31, 2020   0        
Balance at beginning of period at Dec. 31, 2020 $ 126,583 $ 0 $ 28 $ 487,290 $ (361,015) $ 280
Balance at beginning of period, common stock (in shares) at Dec. 31, 2020     27,991,425      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain (loss) on marketable securities (37)         (37)
Foreign currency translation adjustment (460)         (460)
Issuance of common stock for cash, net of issuance costs of $5,893 (in shares)     6,325,000      
Issuance of common stock for cash, net of issuance costs of $5,893 $ 82,657   $ 6 82,651    
Stock option exercises (in shares) 111,804   111,804      
Stock option exercises $ 711     711    
Stock-based compensation (in shares)     134,236      
Stock-based compensation 13,515     13,515    
Employee stock purchase plan shares issued (in shares)     33,641      
Employee stock purchase plan shares issued 440     440    
Issuance of common stock for cashless warrant exercise (in shares)     26,958      
Issuance of common stock for cashless warrant exercise 0          
Exchange of common stock for Series A Common Equivalent Preferred Stock (in shares)   6,666 (6,665,841)      
Stock Issued During Period, Value, Conversion of Convertible Securities 0   $ (6) 6    
Net loss $ (117,683)       (117,683)  
Balance at end of period, preferred stock (in shares) at Dec. 31, 2021 6,666 6,666        
Balance at end of period at Dec. 31, 2021 $ 105,726 $ 0 $ 28 584,613 (478,698) (217)
Balance at end of period, common stock (in shares) at Dec. 31, 2021 27,957,223   27,957,223      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain (loss) on marketable securities $ 39         39
Foreign currency translation adjustment $ (691)         (691)
Stock option exercises (in shares) 35,478   35,478      
Stock option exercises $ 67   $ 1 66    
Stock-based compensation (in shares)     412,628      
Stock-based compensation 9,280     9,280    
Employee stock purchase plan shares issued (in shares)     149,327      
Employee stock purchase plan shares issued 214     214    
Net loss $ (39,616)       (39,616)  
Balance at end of period, preferred stock (in shares) at Dec. 31, 2022 6,666 6,666        
Balance at end of period at Dec. 31, 2022 $ 75,019 $ 0 $ 29 $ 594,173 $ (518,314) $ (869)
Balance at end of period, common stock (in shares) at Dec. 31, 2022 28,554,656   28,554,656